AI assistant
DEXCOM INC — Director's Dealing 2014
Feb 27, 2014
30198_dirs_2014-02-27_cef21530-d63d-462f-87b5-92a84023b326.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2014-02-25
Reporting Person: TOPOL ERIC (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-02-25 | Common Stock | S | 50000.0 | $45.1714 | Disposed | 90909 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 12207 | Direct |
Footnotes
F1: On December 30, 2013, Dr. Topol exercised 98,706 stock options granted to him on July 9, 2009. The 50,000 shares set forth above were sold to cover the tax liability which accrued upon the exercise of the 98,706 stock options.
F2: This transaction was executed in multiple trades at prices ranging from $45.00 to $45.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
F3: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.